IDEXX LABORATORIES INC /DE Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
IDEXX LABORATORIES INC /DE (IDXX) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of $5.95 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-16.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2023-02-16
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2022-12-31 was -$4.41M, a 920.45% decline year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2022-09-30 was $4.63M, a 392.98% increase year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2022-06-30 was $4.30M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2022-03-31 was $1.44M, a 14.97% increase year-over-year.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2022 was $5.95M, a 179.14% increase from fiscal 2021.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2021 was $2.13M.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2020 was -$2.01M, a 656.08% decline from fiscal 2019.
- IDEXX LABORATORIES INC /DE other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2019 was $362.00K, a 85.69% decline from fiscal 2018.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 9 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $220.00K derived: sum of 2 quarters · filed 2023-02-16 | $4.52M derived: sum of 3 quarters · filed 2023-02-16 | $5.95M 10-K · filed 2023-02-16 | ||||
| 2022-09-30 | $4.63M 10-Q · filed 2022-11-01 | $8.93M derived: sum of 2 quarters · filed 2022-11-01 | $10.37M 10-Q · filed 2022-11-01 | $10.91M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2022-06-30 | $4.30M 10-Q · filed 2022-08-02 | $5.73M 10-Q · filed 2022-08-02 | $6.27M derived: sum of 3 quarters · filed 2023-02-16 | $7.21M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2022-03-31 | $1.44M 10-Q · filed 2022-05-04 | $1.97M derived: sum of 2 quarters · filed 2023-02-16 | $2.91M derived: sum of 3 quarters · filed 2023-02-16 | $2.32M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.48M derived: sum of 2 quarters · filed 2023-02-16 | $884.00K derived: sum of 3 quarters · filed 2023-02-16 | $2.13M 10-K · filed 2023-02-16 | ||||
| 2021-09-30 | $940.00K 10-Q · filed 2022-11-01 | $346.00K derived: sum of 2 quarters · filed 2022-11-01 | $1.59M 10-Q · filed 2022-11-01 | -$257.00K derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | -$594.00K 10-Q · filed 2022-08-02 | $655.00K 10-Q · filed 2022-08-02 | -$1.20M derived: sum of 3 quarters · filed 2023-02-16 | -$2.60M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-04 | -$603.00K derived: sum of 2 quarters · filed 2023-02-16 | -$2.01M derived: sum of 3 quarters · filed 2023-02-16 | -$2.82M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$3.26M derived: sum of 2 quarters · filed 2023-02-16 | -$4.07M derived: sum of 3 quarters · filed 2023-02-16 | -$2.01M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | -$1.41M 10-Q · filed 2021-11-02 | -$2.21M derived: sum of 2 quarters · filed 2021-11-02 | -$161.00K 10-Q · filed 2021-11-02 | -$1.24M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$805.00K 10-Q · filed 2021-07-30 | $1.25M 10-Q · filed 2021-07-30 | $166.00K derived: sum of 3 quarters · filed 2022-02-16 | $1.41M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | $2.05M 10-Q · filed 2021-05-04 | $971.00K derived: sum of 2 quarters · filed 2022-02-16 | $2.21M derived: sum of 3 quarters · filed 2022-02-16 | $2.19M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $159.00K derived: sum of 2 quarters · filed 2022-02-16 | $138.00K derived: sum of 3 quarters · filed 2022-02-16 | $362.00K 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $1.24M 10-Q · filed 2020-10-29 | $1.97M 10-Q · filed 2019-10-31 | $1.22M derived: sum of 2 quarters · filed 2020-10-29 | $1.44M 10-Q · filed 2020-10-29 | $2.33M 10-Q · filed 2019-10-31 | $2.13M derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-06-30 | -$21.00K 10-Q · filed 2020-07-31 | -$169.00K 10-Q · filed 2019-08-01 | $203.00K 10-Q · filed 2020-07-31 | $362.00K 10-Q · filed 2019-08-01 | $886.00K derived: sum of 3 quarters · filed 2021-02-12 | $948.00K derived: sum of 4 quarters · filed 2021-02-12 | ||
| 2019-03-31 | $224.00K 10-Q · filed 2020-04-30 | $531.00K 10-Q · filed 2019-05-01 | $907.00K derived: sum of 2 quarters · filed 2021-02-12 | $969.00K derived: sum of 3 quarters · filed 2021-02-12 | $3.13M derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2018-12-31 | $683.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $745.00K derived: sum of 2 quarters · filed 2021-02-12 | $2.91M derived: sum of 3 quarters · filed 2021-02-12 | $2.53M 10-K · filed 2021-02-12 | $2.85M 10-K · filed 2019-02-15 | |||
| 2018-09-30 | $62.00K 10-Q · filed 2019-10-31 | $2.22M derived: sum of 2 quarters · filed 2019-10-31 | $1.85M 10-Q · filed 2019-10-31 | $1.58M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-06-30 | $2.16M 10-Q · filed 2019-08-01 | $1.78M 10-Q · filed 2019-08-01 | $1.51M derived: sum of 3 quarters · filed 2020-02-14 | -$321.00K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-03-31 | -$377.00K 10-Q · filed 2019-05-01 | -$646.00K derived: sum of 2 quarters · filed 2020-02-14 | -$2.48M derived: sum of 3 quarters · filed 2020-02-14 | |||||
| 2017-12-31 | -$269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | -$2.10M derived: sum of 2 quarters · filed 2020-02-14 | -$5.30M 10-K · filed 2020-02-14 | |||||
| 2017-09-30 | -$1.84M 10-Q · filed 2018-11-01 | -$5.04M 10-Q · filed 2018-11-01 | ||||||
| 2016-12-31 | $2.17M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |